AT247

BIOLOGICAL2 trials

Sponsors

Arecor Limited

Conditions

Diabetes Mellitus, Type 1

Phase 1

AT247, NovoRapid® and Fiasp® in Glucose Clamp Study

CompletedNCT03959514

Arecor LimitedDiabetes Mellitus, Type 1

Start: 2019-04-12End: 2019-08-08Updated: 2019-09-30

AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study

CompletedNCT05184868

Arecor LimitedDiabetes Mellitus, Type 1

Start: 2022-01-03End: 2022-09-09Updated: 2022-09-13